F.D.A. Authorizes a New Covid Drug to Protect High-Risk People

Pemgarda, available in the coming weeks, is intended for immunocompromised people who are unlikely to mount an adequate response after vaccination.

Source: NYT Health - March 25, 2024 Category: Consumer Health News Authors: Dani Blum Tags: Coronavirus (2019-nCoV) Immune System Drugs (Pharmaceuticals) Antibodies Transplants Source Type: news